Suppr超能文献

小肠结肠炎耶尔森菌血清抗性蛋白YadA和Ail与补体调节蛋白C4b结合蛋白相结合。

Yersinia enterocolitica serum resistance proteins YadA and ail bind the complement regulator C4b-binding protein.

作者信息

Kirjavainen Vesa, Jarva Hanna, Biedzka-Sarek Marta, Blom Anna M, Skurnik Mikael, Meri Seppo

机构信息

Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Helsinki, Finland.

出版信息

PLoS Pathog. 2008 Aug 29;4(8):e1000140. doi: 10.1371/journal.ppat.1000140.

Abstract

Many pathogens are equipped with factors providing resistance against the bactericidal action of complement. Yersinia enterocolitica, a Gram-negative enteric pathogen with invasive properties, efficiently resists the deleterious action of human complement. The major Y. enterocolitica serum resistance determinants include outer membrane proteins YadA and Ail. Lipopolysaccharide (LPS) O-antigen (O-ag) and outer core (OC) do not contribute directly to complement resistance. The aim of this study was to analyze a possible mechanism whereby Y. enterocolitica could inhibit the antibody-mediated classical pathway of complement activation. We show that Y. enterocolitica serotypes O:3, O:8, and O:9 bind C4b-binding protein (C4bp), an inhibitor of both the classical and lectin pathways of complement. To identify the C4bp receptors on Y. enterocolitica serotype O:3 surface, a set of mutants expressing YadA, Ail, O-ag, and OC in different combinations was tested for the ability to bind C4bp. The studies showed that both YadA and Ail acted as C4bp receptors. Ail-mediated C4bp binding, however, was blocked by the O-ag and OC, and could be observed only with mutants lacking these LPS structures. C4bp bound to Y. enterocolitica was functionally active and participated in the factor I-mediated degradation of C4b. These findings show that Y. enterocolitica uses two proteins, YadA and Ail, to bind C4bp. Binding of C4bp could help Y. enterocolitica to evade complement-mediated clearance in the human host.

摘要

许多病原体都具备抵抗补体杀菌作用的因子。小肠结肠炎耶尔森菌是一种具有侵袭性的革兰氏阴性肠道病原体,能有效抵抗人类补体的有害作用。小肠结肠炎耶尔森菌的主要血清抗性决定因素包括外膜蛋白YadA和Ail。脂多糖(LPS)O抗原(O-ag)和外核心(OC)并不直接参与补体抗性。本研究的目的是分析小肠结肠炎耶尔森菌抑制抗体介导的补体激活经典途径的可能机制。我们发现小肠结肠炎耶尔森菌O:3、O:8和O:9血清型能结合C4b结合蛋白(C4bp),它是补体经典途径和凝集素途径的抑制剂。为了鉴定小肠结肠炎耶尔森菌O:3血清型表面的C4bp受体,对一组以不同组合表达YadA、Ail、O-ag和OC的突变体进行了结合C4bp能力的测试。研究表明,YadA和Ail都作为C4bp受体起作用。然而,Ail介导的C4bp结合被O-ag和OC阻断,只有在缺乏这些LPS结构的突变体中才能观察到。与小肠结肠炎耶尔森菌结合的C4bp具有功能活性,并参与了I因子介导的C4b降解。这些发现表明,小肠结肠炎耶尔森菌利用YadA和Ail这两种蛋白结合C4bp。C4bp的结合可能有助于小肠结肠炎耶尔森菌在人类宿主中逃避补体介导的清除。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de98/2516929/e3c02f51bce5/ppat.1000140.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验